Literature DB >> 15529270

Dual phases of apoptosis in pneumococcal meningitis.

Lauren Mitchell1, S Hope Smith, Johann S Braun, Karl-Heinz Herzog, Joerg R Weber, Elaine I Tuomanen.   

Abstract

Significant injury during bacterial meningitis arises from mechanisms of neuronal apoptosis, particularly in the hippocampus. Apoptosis can involve both the caspase-dependent and the caspase-independent pathway, and, although both pathways have been implicated in pneumococcus-induced neuronal cell death, their relative contributions in vivo are unclear. We used mice deficient in the activation of caspase-3, ATM, and p53 to examine the role that caspase-dependent apoptosis plays in neuronal death in the context of pneumococcal meningitis. The overall symptomatology of acute infection was similar in all mice tested, indicating that late sequelae are the clinical manifestations of neuronal death. Two phases of apoptosis were discernible: neuronal injury at 18 h after infection was independent of the caspase-3 pathway, and neuronal cell death at 24 h after infection was attenuated in the absence of the caspase-3 pathway. We conclude that treatments to increase the survival rate of neurons in patients with meningitis will need to take into account at least these 2 mechanisms of damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529270     DOI: 10.1086/425520

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Pathophysiology and treatment of bacterial meningitis.

Authors:  Olaf Hoffman; R Joerg Weber
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

2.  Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways.

Authors:  Daniela Bermpohl; Annett Halle; Dorette Freyer; Emilie Dagand; Johann S Braun; Ingo Bechmann; Nicolas W J Schröder; Joerg R Weber
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

3.  Cell wall-mediated neuronal damage in early sepsis.

Authors:  Carlos J Orihuela; Sophie Fillon; S Hope Smith-Sielicki; Karim C El Kasmi; Geli Gao; Konstantinos Soulis; Avinash Patil; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy.

Authors:  Colin Kietzman; Elaine Tuomanen
Journal:  ACS Infect Dis       Date:  2019-07-03       Impact factor: 5.084

Review 5.  The pneumococcus: epidemiology, microbiology, and pathogenesis.

Authors:  Birgitta Henriques-Normark; Elaine I Tuomanen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

6.  Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Olivier Coquoz; Brad Rice; Steven Smith; Pamela R Contag; Tony Purchio
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 7.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

8.  JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis.

Authors:  Matthias D Sury; Claudia Agarinis; Hans-Rudolf Widmer; Stephen L Leib; Stephan Christen
Journal:  Neurobiol Dis       Date:  2008-07-18       Impact factor: 5.996

9.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

10.  Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.

Authors:  Geeta Ramesh; Juan T Borda; Amy Gill; Erin P Ribka; Lisa A Morici; Peter Mottram; Dale S Martin; Mary B Jacobs; Peter J Didier; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 9.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.